APOA1 and atherosclerosis: We compared the MPO oxidation resistant 4WF apoA1 isoform vs. the wild type human apoA1 in the context of the LDLr KO mouse model of atherosclerosis progression, and a diet switch plus MTP inhibitor atherosclerosis regression model, developed by Fisher and colleagues [18].